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This final technical report is for our DOE grant DE-FG02-91ER61138 entitled 
"Subcellular boron and fluorine distributions with SIMS ion microscopy in BNCT and 
cancer research". This grant was in “NO Cost Extension Status” from 7/1/05 to 6/30/07. 
The development of a secondary ion mass spectrometry (SIMS) based technique of Ion 
Microscopy in boron neutron capture therapy (BNCT) was the main goal of this project, 
so that one can study the subcellular location of boron-10 atoms and their partitioning 
between the normal and cancerous tissue. This information is fundamental for the 
screening of boronated drugs appropriate for neutron capture therapy of cancer. Our 
studies at Cornell concentrated mainly on studies of glioblastoma multiforme (GBM). 
The early years of the grant were dedicated to the development of cryogenic methods and 
correlative microscopic approaches so that a reliable subcellular analysis of boron-10 
atoms can be made with SIMS. In later years SIMS was applied to animal models and 
human tissues of GBM for studying the efficacy of potential boronated agents in BNCT. 
Under this grant the SIMS program at Cornell attained a new level of excellence and 
collaborative SIMS studies were published with leading BNCT researchers in the U.S. A 
list of peer-reviewed publications under this grant is provided below and a few highlights 
are discussed in this report.     
 
SIMS studies in T98G human glioblastoma cells for understanding mechanistic 
aspects of boronophenylalanine (BPA) uptake in tumor cells  
  
The BPA is still being used in experimental trials of GBM, melanoma, and liver 
metastases in some European and Asian countries. To understand why BPA selectively 
targets the cancer cells has long remained a challenging question in BPA-mediated 
BNCT. This is one important area of BNCT research where SIMS has played a pivotal 
role by making sub-cellular scale observations of boron-delivery from BPA in animal and 
cell culture models of GBM. The infiltrating tumor cells in the normal brain are the main 
targets of clinical BNCT. Since infiltrating tumor cells are protected by the blood-brain-
barrier, boron-delivery to these cells can be significantly different from the cells in the 
main tumor mass where the blood-brain-barrier is compromised. The application of 
SIMS, in conjunction with cryogenic sampling, has the capability for the assessment of 
single cell boron measurements for resolving these complex issues of the efficacy of a 
particular boron containing drug in targeting the relevant tumor cells in GBM. A brief 
discussion of our SIMS observations on BPA is discussed below.     
 
Our SIMS observations provided the first direct evidence in cryogenically prepared cells 
that BPA targets infiltrating tumor cells in the normal brain, also known as the satellite or 
clusters of malignant cells peppered in the normal brain far away from the main tumor 
mass (Smith et al., Cancer Res. 56: 4302-4306, 1996). This paper also indicated a main 
flaw in the ASSUMPTION that is made for radiation dosimetry calculations in clinical 
BNCT: the boron content of tumor cells in the main tumor mass is the same as the 
infiltrating tumor cells. Our SIMS observations indicated that the infiltrating tumor cells 
had approximately 50% of boron than found in tumor cells in the main tumor mass. 
These observations had critical implications in clinical BNCT. Further SIMS studies of 
BPA in animal (Smith et al., Cancer Research, 61: 8179-8187, 2001) and cell culture 
models of GBM (Chandra et al., Radiation Research, 157: 700-710, 2002) indicated that 
a longer exposure of BPA can elevate the boron content of infiltrating tumor cells and 
provide a nearly 3:1 partitioning between the infiltrating tumor cells and the normal 
brain. Even though our SIMS observations were limited to cell culture and rat models of 
GBM, the 6 hr. long BPA exposure supported by our studies was clinically implemented 
in experimental trials of GBM in Sweden. However, the reasons behind this increased 
boron uptake at the longer 6 hr. BPA exposure (versus the shorter 1 and 2 h. exposures) 
remained unclear. To understand the mechanism of this increased uptake of 10B from 
BPA, we developed a SIMS approach for directly imaging the net entry of 13C15N 
isotopically labeled amino acids. By imaging the marker label at mass 28(13C15N) with 
SIMS, we were able to study the subcellular distribution of phenylalanine. Further 
extension of this study by using a direct comparison of 10B entry from BPA to the net 
entry of the isotopically labeled phenylalanine provided unique SIMS observations 
relevant to the mechanistic aspect of BPA uptake and metabolism in cells. First, there 
was a comparable increase in the labeled amino acid or in the 10B from BPA between the 
2 and 6 hr. exposures of T98G glioblastoma cells. Second, the subcellular distribution of 
the 28CN label was different than 10B from BPA. The 28CN was distributed throughout 
the cell, but 10B was distinctly lower in the mitochondria-rich perinuclear region of 
T98G glioblastoma cells (as revealed by laser confocal microscopy imaging of 
rhodamine 123 fluorescence). These observations indicate that (i) the higher uptake of 
BPA and 28CN-labeled phenylalanine at 6 hr. vs. 2 hr plausibly represents a basic 
similarity between BPA and phenylalanine in a time-dependent entry mechanism through 
the plasma membrane in response to cellular requirements for the amino acid and (ii) 
intracellular processes recognize BPA as a different molecule than phenylalanine and the 
metabolism of BPA is distinctly different than that of phenylalanine. Further 
understanding of the higher accumulation of BPA with longer exposures was provided by 
the Cell Cycle preference of BPA uptake. By pulsing 5-bromodeoxyuridine with BPA, 
SIMS was able to provide the boron concentrations in individual cells in the DNA 
synthesizing phase (S-phase) of the cell cycle. These observations revealed elevated 
levels of boron from BPA in the S-phase cells. Therefore, the movement of the cell cycle 
through the S-phase will be at least one reason that would partially enhance the boron 
uptake of brain tumor cells with longer exposures of BPA. A major publication has been 
communicated on these observations (Chandra, S. and Lorey, D. R. SIMS ion 
microscopy imaging of boronophenylalanine and 13C15N-labeled phenylalanine in 
human glioblastoma cells: Relevance of subcellular scale observations to BPA-mediated 
boron neutron capture therapy of cancer. Int. J. Mass Spectrom. 260: 90-101, 2007). 
 
 SIMS studies of boron-delivery to mitotic cells  
 
As many tumor cells can be found in the mitotic M phase of the cell cycle, the evaluation 
of their boron-targeting has always remained a question in BPA mediated BNCT. In a 
recent SIMS publication, we now show the subcellular scale boron distribution in 
metaphase cells. These evaluations included studies of two BNCT agents, BPA and N4. 
The N4 is a boron analogue of thymidine with characteristics of the S-phase targeting. 
Our SIMS observations in this study revealed that mitotic cells have different 
characteristics of boron uptake than interphase cells and should be evaluated for this 
difference for each boron compound in clinical BNCT (Chandra, S., Tjarks, W., Lorey, 
D. R., and Barth, R. F. Quantitative subcellular imaging of boron compounds in 
individual mitotic and interphase human glioblastoma cells with SIMS. J. Microsc. 229: 
92-103, 2008). The 3-D SIMS imaging methodology shown in this paper should be 
feasible to future screening of any boron containing agents in mitotic cells.   
 
SIMS studies of GB-10 and BPA in hamster cheek pouch oral cancer model 
 
In April 2005, the PI, Dr. Subhash Chandra visited Argentina to do collaborative research 
with Dr. Amanda Schwint of the National Atomic Energy Commission, Buenos Aires 
(April 11-19, 2005).  This visit was supported by DOE’s sister lab program. SIMS studies 
were deemed important for observing the distribution of boron from BPA and GB-10 in 
cancerous and normal tissues of the hamster cheek pouch. Initial SIMS observations in 
this collaboration revealed a consistent pattern of a higher accumulation of boron from 
BPA in the nuclei of cells in the cancerous tissue. The boron from GB-10 was observed 
to be distributed in low concentration throughout the tissue.   
 
Other studies in partial support by the grant     
  
In several publications this grant is acknowledged for the partial support. These 
publications represent diverse fields of fundamental cell biology and applied biomedical 
research with SIMS and in some cases extend the application of methods developed 
under this grant. A detailed study of cell division was completed in normal renal 
epithelial LLC-PK1 cells for understanding the location of calcium stores in all various 
phases of mammalian cell division (Chandra, S. Quantitative imaging of subcellular 
calcium stores in mammalian LLC-PK1 epithelial cells undergoing mitosis by SIMS ion 
microscopy. Eur. J. Cell Biol., 84: 783-797, 2005).  What is remarkable about this work 
is that in comparison to the depletion of calcium stores observed in the spindle of 
metaphase human glioblastoma cells, revealed by SIMS in a previous study (Chandra, S. 
3D subcellular SIMS imaging in cryogenically prepared single cells. Applied Surface 
Science, 231-232: 467-469, 2004), the normal cells show the presence of well aligned 
calcium stores in the spindle of metaphase cells. Taken together, SIMS observations in 
these two cell types provide valuable hints to the plausible alteration of calcium signaling 
in dividing glioblastoma cells.  
 
A study of Gd isotope localization was completed with SIMS in the skin tissue of patients 
suffering from nephrogenic systemic fibrosis. SIMS is currently the only technique to 
reveal the presence of very low concentrations of soluble Gd associated with the skin 
tissue of patients treated with MRI contrast enhancing agents (Abraham et al., SIMS 
imaging of gadolinium isotopes in tissue from nephrogenic systemic fibrosis patients: 
Release of free Gd from MRI contrast agents. Appl. Surf. Sci., 2008).  
 
In another unique study the SIMS methodology developed for 13C  imaging under the 
current grant was used for single cell imaging of soil bacterial population for degradation 
of organic molecules (Chandra et al., Dynamic SIMS ion microscopy imaging of 
individual bacterial cells for studies of isotopically labeled molecules. Appl. Surf. Sci. 
2008). This study has opened new avenues of SIMS research in microbiology for 
identification of soil bacterial cells involved with degradation of organic molecules.  
 
The grant is acknowledged in a review article on cryogenic sample preparation for 
subcellular localization of elements and molecules with SIMS presented in a roundtable 
discussion at the XVI International Conference on Secondary Ion Mass Spectrometry 
(SIMS), held in Kanazawa, Japan, 2007 (Chandra, S. Challenges of biological sample 
preparation for SIMS imaging of elements and molecules at subcellular resolution. Appl. 
Surf. Sci., in press). The grant is also acknowledged in a recent study which shows that 
by using 5-bromouridine and 5-iododeoxyuridine both RNA distribution and DNA 
replication can be imaged in the same cell by SIMS (Chandra, S.  Subcellular imaging of 
RNA distribution and DNA replication in single mammalian cells with SIMS: the 
localization of heat shock induced RNA in relation to the distribution of intranuclear 
bound calcium. J. Microsc. in press). These methodological developments further 
enhance the utility of SIMS for drug screening applications in BNCT and other areas of 
medical research.     
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